Regenerative Orthobiologics Center
The poor regeneration potential of musculoskeletal tissues combined with an increased life expectancy is demanding more effective, minimally invasive treatment options. Orthobiologics, substances that can facilitate healing, often lack a standardized evaluation. Our program’s mission is to keep patients healthy and active by evaluating and refining existing orthobiologic therapies and by discovering, developing and translating novel orthobiologics for musculoskeletal disorders.
Discover, translate and evaluate novel regenerative (stem cell and gene) therapies and biomarkers to refine treatment success rates in patients suffering from orthopaedic conditions.
Discover and optimize clinical imaging modalities for an improved evaluation of orthopaedic conditions and a more accurate assessment of responses to therapeutic treatments.
Establish registries and biorepositories from patients being treated with currently available orthobiologic treatments so that they can be further studied, not only for a deeper understanding, but for potential development of new therapies.
Our vision is to bridge translational gaps in the use of orthobiologic treatments and provide new solutions for today’s challenges. Development, evaluation, refinement and translation of novel orthobiologic therapeutic options for musculoskeletal disorders will help indicate the appropriate therapeutic approach and delay the need for surgical procedures.
Meet the Team
The Regenerative Orthobiologics Center is comprised of a diverse, expert team of basic and translational scientists, clinicians and clinical trialists at the Cedars-Sinai Board of Governors Regenerative Medicine Institute, Orthopaedics Department and Kerlan-Jobe Institute.
To ensure synchronized and far-reaching results, the Regenerative Orthobiologics Center works closely with the Biologic Association, an initiative of leading U.S. hospitals in orthopaedics. The Biologic Association mission is to foster and convene a collaboration for shared and coordinated efforts to speak with a unified voice in the musculoskeletal biologics environment.
Currently enrolling: Identification of cell and protein biomarkers in platelet-rich plasma to improve individual pain outcomes in knee osteoarthritis. Please contact Jasmine Galloway at email@example.com.
Christopher J. Zarembinski, MD, is a team member of the Regenerative Orthobiologics Center, which is part of the Regenerative Medicine Institute at Cedars-Sinai Medical Center. The orthobiologics program mission is to keep patients healthy and active by evaluating and refining existing orthobiologic therapies and by discovering, developing and translating novel orthobiologics for musculoskeletal disorders.
Have Questions or Need Help?
If you have questions or would like to learn more about the Regenerative Orthobiologics Center, please contact Program Manager Juliane Glaeser, PhD.
Advanced Health Sciences Pavilion
127 S. San Vicente Blvd., Suite A8521
Los Angeles, CA 90048